Back to D1 Capital Partners L.P. D1 Capital Partners L.P.

ELVELV
11 quarters

Position history for D1 Capital Partners L.P.D1 Capital Partners L.P.'s holdings in ELEVANCE HEALTH INC FORMERLY

No. D1 Capital Partners exited its ELV (Elevance Health) position in Q3 2025. Its Q2 2025 13F listed 326,411 shares worth $127M. D1 Capital Partners first reported ELV in Q1 2023 and held it in 9 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$314.1M

Total Shares Change

-683,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$316.82
0
2025-Q2
Decreased
326,411
-43.6%
$127M1.8%$379.31
0
2025-Q1
Decreased
578,411
-27.6%
$251.6M3.9%$422.30
0
2024-Q4
New
799,000
-
$294.8M4.9%$356.67
87
2024-Q3
Exited
0
-100.0%
$00.0%$500.71
0
2024-Q2
Decreased
295,932
-44.1%
$160.4M2.7%$520.20
0
2024-Q1
Decreased
529,632
-23.1%
$274.6M4.2%$496.30
0
2023-Q4
Decreased
689,032
-28.1%
$324.9M5.7%$449.88
0
2023-Q3
Increased
959,032
+38.8%
$417.6M6.0%$414.13
81
2023-Q2
Increased
690,732
+1.1%
$306.9M5.9%$421.16
62
2023-Q1
New
683,000
-
$314.1M5.9%$434.47
97

Other major holders of ELV: BlackRock Finance, Inc., VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used